Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-31

Clinical Trial Update: Effect of Amitriptyline and Trifluoperazine on Patients With Functional Dyspepsia [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 2/Phase 3 study evaluating amitriptyline and trifluoperazine for functional dyspepsia, with recruitment currently o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • amitriptyline (amitriptyline)
  • trifluoperazine (trifluoperazine)

Snippet

Sponsor: Md. Moktadirul Hoque Shuvo | Conditions: Functional Dyspepsia | Phase 2, Phase 3 | Status: RECRUITING